We at Infectious Diseases Hub recently spoke to Peter Openshaw, Professor of Experimental Medicine at Imperial College London (UK), about his research into respiratory viruses and the challenges currently facing science policy and funding.
Browsing: Clinical > Vaccines
The National Institutes of Health (MD, USA) have begun a Phase I clinical trial examining a vaccine intended to provide broad protection against a range of mosquito-borne diseases by targeting the insect’s saliva.
Researchers have demonstrated that a new whole-parasite vaccine could provide up to 100% protection in clinical trials carried out at the University of Tübingen (Germany).
Researchers have created a model to assess the benefits of vaccination on the burden of non-typhoidal salmonella in Mali; the research could inform policy in many countries where there is high risk of these infections.
Researchers have pioneered an mRNA-based vaccine against Zika that has demonstrated promising results in pre-clinical trials on mice and monkeys.
In this review the author looks at the progress of vaccine development towards mosquito-borne viral diseases, such as Zika and chikungunya.
Could one vaccine dose be as effective as two or three doses at preventing persistent HPV infection in the cervix in young women? This review discusses HPV vaccine coverage and the possibility of a one-dose schedule.
The authors of this editorial look back over the work that has been conducted towards developing a universal vaccine for influenza.